Unknown

Dataset Information

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project.


ABSTRACT:

Background

Pyrazinamide and fluoroquinolones are essential antituberculosis drugs in new rifampicin-sparing regimens. However, little information about the extent of resistance to these drugs at the population level is available.

Methods

In a molecular epidemiology analysis, we used population-based surveys from Azerbaijan, Bangladesh, Belarus, Pakistan, and South Africa to investigate resistance to pyrazinamide and fluoroquinolones among patients with tuberculosis. Resistance to pyrazinamide was assessed by gene sequencing with the detection of resistance-conferring mutations in the pncA gene, and susceptibility testing to fluoroquinolones was conducted using the MGIT system.

Findings

Pyrazinamide resistance was assessed in 4972 patients. Levels of resistance varied

SUBMITTER: Zignol M 

PROVIDER: S-EPMC5030278 | biostudies-literature | 2016 Oct

REPOSITORIES: biostudies-literature